Page last updated: 2024-10-21

alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid and Bipolar Disorder

alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid has been researched along with Bipolar Disorder in 2 studies

alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid: An IBOTENIC ACID homolog and glutamate agonist. The compound is the defining agonist for the AMPA subtype of glutamate receptors (RECEPTORS, AMPA). It has been used as a radionuclide imaging agent but is more commonly used as an experimental tool in cell biological studies.

Bipolar Disorder: A major affective disorder marked by severe mood swings (manic or major depressive episodes) and a tendency to remission and recurrence.

Research Excerpts

ExcerptRelevanceReference
"Lithium has been the gold standard in the treatment of bipolar disorder (BPD) for 60 y."3.76A kinesin signaling complex mediates the ability of GSK-3beta to affect mood-associated behaviors. ( Blumenthal, R; Drevets, W; Du, J; Hunsberger, JG; Khairova, R; Liu, L; Machado-Vieira, R; Manji, HK; Tragon, T; Wang, Y; Wang, YT; Wei, Y, 2010)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zarate, CA1
Machado-Vieira, R2
Du, J1
Wei, Y1
Liu, L1
Wang, Y1
Khairova, R1
Blumenthal, R1
Tragon, T1
Hunsberger, JG1
Drevets, W1
Wang, YT1
Manji, HK1

Other Studies

2 other studies available for alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid and Bipolar Disorder

ArticleYear
GSK-3: A key regulatory target for ketamine's rapid antidepressant effects mediated by enhanced AMPA to NMDA throughput.
    Bipolar disorders, 2016, Volume: 18, Issue:8

    Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Antidepressive Agents; Bipolar Disorder; G

2016
A kinesin signaling complex mediates the ability of GSK-3beta to affect mood-associated behaviors.
    Proceedings of the National Academy of Sciences of the United States of America, 2010, Jun-22, Volume: 107, Issue:25

    Topics: Affect; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Antidepressive Agents; Bi

2010